Equity Analysis /
Egypt

Egypt Pharma 2022: Well positioned for recovery, supported by favorable dynamics

  • Sector outlook, hopes, fears, and top picks

  • Sector valuation table and inter-company comparison

  • Individual pharma players: 2022 fundamental review

Mariam Wael
Merna Arafat
Al Ahly Pharos Securities Brokerage
25 November 2021